 | Up a level |
Glen, Claire, Tan, Yun Yi, Waterston, Ashita, Evans, Thomas R Jeffry, Jones, Robert J 
ORCID: 0000-0001-5608-001X, Petrie, Mark C ORCID: 0000-0002-6333-9496 and Lang, Ninian N
(2022)
Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: <i>JACC: CardioOncology</i> State-of-the-Art Review.
JACC. CardioOncology, 4 (1).
pp. 1-18.
Kristeleit, Rebecca ORCID: 0000-0003-3825-1326, Plummer, Ruth, Jones, Robert ORCID: 0000-0001-5608-001X, Carter, Louise, Blagden, Sarah ORCID: 0000-0001-8783-3491, Sarker, Debashis ORCID: 0000-0003-4814-8429, Arkenau, Tobias, Evans, Thomas R Jeffry, Danson, Sarah, Symeonides, Stefan N ORCID: 0000-0002-9892-9314 et al (show 4 more authors)
(2023)
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer.
British journal of cancer, 129 (1).
pp. 38-45.